- Home
- CLIR vs DRRX Comparison
CLIR vs DRRX Comparison
Compare CLIR & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLIR
- DRRX
- Stock Information
- Founded
- CLIR 2008
- DRRX 1998
- Country
- CLIR United States
- DRRX United States
- Employees
- CLIR N/A
- DRRX N/A
- Industry
- CLIR Industrial Machinery/Components
- DRRX Biotechnology: Pharmaceutical Preparations
- Sector
- CLIR Industrials
- DRRX Health Care
- Exchange
- CLIR Nasdaq
- DRRX Nasdaq
- Market Cap
- CLIR 41.7M
- DRRX 44.4M
- IPO Year
- CLIR 2012
- DRRX 2000
- Fundamental
- Price
- CLIR $1.04
- DRRX $0.97
- Analyst Decision
- CLIR Strong Buy
- DRRX Buy
- Analyst Count
- CLIR 1
- DRRX 2
- Target Price
- CLIR $6.00
- DRRX $5.00
- AVG Volume (30 Days)
- CLIR 212.6K
- DRRX 88.6K
- Earning Date
- CLIR 11-14-2024
- DRRX 11-13-2024
- Dividend Yield
- CLIR N/A
- DRRX N/A
- EPS Growth
- CLIR N/A
- DRRX N/A
- EPS
- CLIR N/A
- DRRX N/A
- Revenue
- CLIR $4,280,000.00
- DRRX $8,594,000.00
- Revenue This Year
- CLIR $69.16
- DRRX N/A
- Revenue Next Year
- CLIR $440.76
- DRRX $3.07
- P/E Ratio
- CLIR N/A
- DRRX N/A
- Revenue Growth
- CLIR 263.02
- DRRX N/A
- 52 Week Low
- CLIR $0.62
- DRRX $0.48
- 52 Week High
- CLIR $1.72
- DRRX $1.88
- Technical
- Relative Strength Index (RSI)
- CLIR 59.41
- DRRX 36.61
- Support Level
- CLIR $0.85
- DRRX $0.84
- Resistance Level
- CLIR $1.28
- DRRX $1.36
- Average True Range (ATR)
- CLIR 0.11
- DRRX 0.13
- MACD
- CLIR 0.02
- DRRX -0.03
- Stochastic Oscillator
- CLIR 47.83
- DRRX 23.08
About CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .